UroGen Pharma Ltd. (URGN) Deep Dive Video

A first-in-class bladder cancer chemoablation launch (now unblocked by a permanent J-code) creates asymmetric upside—if UroGen can convert urologists from surgery to office-based drug therapy fast enough.